@misc{indiciae840af358c48f,
  title = {SARS-CoV-2 differs from SARS-CoV in the requirements for receptor expression and proteolytic activation to trigger cell-cell fusion and is not inhibited by Bromhexine},
  author = {Hörnich, B. F. and Grosskopf, A. K. and Schlagowski, S. and Tenbusch, M. and Neipel, F. and Hahn, A. S.},
  year = {2020},
  doi = {10.1101/2020.07.25.221135},
  url = {https://www.biorxiv.org/content/10.1101/2020.07.25.221135v1},
  note = {Source identifier: 10.1101/2020.07.25.221135}
}